Advertisement

Hypertensive Crisis

  • Kathleen J. Brennan
  • Jesse Goldman
  • Gilbert E. D’Alonzo
Chapter

Abstract

Understand the difference between malignant hypertension, hypertensive emergency, and hypertensive urgency. Understand the pathophysiology of a hypertensive crisis. Evaluate and diagnose hypertensive crisis using history, physical examination, and laboratory studies. Know the various classes of drugs to treat hypertensive crisis, their mechanisms of action, and their use in treating hypertensive emergencies. Recognize the secondary causes of hypertensive emergencies and the drugs used in their treatment.

Keywords

Blood Pressure Aortic Dissection Systemic Blood Pressure Hypertensive Crisis Hypertensive Emergency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hajjar I, Kotchen JM, Kotchen TA. Hypertentsion: trends in prevalence, incidence, and control. Ann Rev Public Health. 2006;27: 465-490.CrossRefGoogle Scholar
  2. 2.
    Cutler JA, Sorlie PD, Wolz M, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818-827.PubMedCrossRefGoogle Scholar
  3. 3.
    Chobanian AV, Bakris GL, Black HR, Cushman WC. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.PubMedCrossRefGoogle Scholar
  4. 4.
    Bennett NM, Shea S. Hypertensive emergency: case criteria sociodemographic profile, and previous care of 100 cases. Am J Public Health. 1988;78:636-640.PubMedCrossRefGoogle Scholar
  5. 5.
    Anon. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993;153:154-183.CrossRefGoogle Scholar
  6. 6.
    Gudbrandsson T. Malignant hypertension: a clinical follow-up study with special reference to renal and cardiovascular function and immunogenetic factors. Acta Med Scand. 1981;suppl 650:1-62.Google Scholar
  7. 7.
    Zampaglione B, Pascale C, Marchisio M, et al. Hypertentive urgencies and emergencies: prevalence and clinical presentation. Hypertension. 1998;27:144-147.CrossRefGoogle Scholar
  8. 8.
    Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24:135-146.PubMedCrossRefGoogle Scholar
  9. 9.
    Potter JF. Malignant hypertension in the elderly. Q J Med. 1995; 86:641-647.Google Scholar
  10. 10.
    Tisdale JE, Huang MB, Borzak S, et al. Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract. 2004;21:420-424.PubMedCrossRefGoogle Scholar
  11. 11.
    Webster J, Petrie JC, Jeffers TA, et al. Accelerated hypertension patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med. 1993;96:485-493.CrossRefGoogle Scholar
  12. 12.
    Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol. 1998;9:133-142.PubMedGoogle Scholar
  13. 13.
    Linfors EW, Feussner JR, Blessing CL, et al. Spurious hypertension in the obese patient: effect of sphyganomanometer cuff size on prevalence of hypertension. Arch Intern Med. 1984;144:1482-1485.PubMedCrossRefGoogle Scholar
  14. 14.
    Strandgaard S, Olesen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ. 1973;1:507-510.PubMedCrossRefGoogle Scholar
  15. 15.
    Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000; 356:411-417.PubMedCrossRefGoogle Scholar
  16. 16.
    Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest. 2002;122:311-328.PubMedCrossRefGoogle Scholar
  17. 17.
    Estera AL, Miller CC III, Safi HJ, et al. Outcomes of medical management of acute type B aortic dissection. Circulation. 2006;114:1384-1389.Google Scholar
  18. 18.
    Marik PE, Varon J. Hypertensive crisis: challenges and management. Chest. 2007;131:1949-1962.PubMedCrossRefGoogle Scholar
  19. 19.
    Hebert CJ, Vidt DG. Hypertensive crisis. Prim Care Clin Office Pract. 2008;35:475-487.CrossRefGoogle Scholar
  20. 20.
    Friederich JA, Butterworth JF. Sodium nitroprusside twenty years and counting. Anes Analg. 1995;81:152-162.Google Scholar
  21. 21.
    Mann T, Cohn PF, Holman LB, et al. Effect of nitroprusside on regional myocardial blood flow in coronary artery disease: results in 25 patients and comparison with nitroglycerin. Circulation. 1978;57:732-738.PubMedCrossRefGoogle Scholar
  22. 22.
    Cohn JN, Franciosa JA, Francis GS, et al. Effect of short-term infusion of sodium nitoprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterens Administration cooperative study. N Engl J Med. 1982;306:1129-1135.PubMedCrossRefGoogle Scholar
  23. 23.
    Anile C, Zanghi F, Bracli A, et al. Sodium nitroprusside and intracranial pressure. Acta Neurochir. 1981;58:203-211.PubMedCrossRefGoogle Scholar
  24. 24.
    Robin ED, McCauley R. Nitroprusside-related cyanide poisoning. Chest. 1992;102:1842-1845.PubMedCrossRefGoogle Scholar
  25. 25.
    Shepherd AM, Ludden TM, McNay JL, et al. Hydralazine kinetics after single and repeated oral doses. Clin Pharmacol Ther. 1980; 28:804-811.PubMedCrossRefGoogle Scholar
  26. 26.
    Ludden TM, Shepherd AM, McNay JL, et al. Hydralazine kinetics in hypertensive patients after intravenous administration. Clin Pharmacol Ther. 1980;28:736-742.PubMedCrossRefGoogle Scholar
  27. 27.
    Lund-Johansen P. Pharmacology of combined alpha-beta-blockade II. Hemodynamic effects of labetalol. Drugs. 1984;28(suppl 2): 35-50.PubMedCrossRefGoogle Scholar
  28. 28.
    Shusterman NH, Elliott WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med. 1993;95:161-168.PubMedCrossRefGoogle Scholar
  29. 29.
    Rodriguez G, Varon J. Clevidipine; a unique agent for the critical care practitioner. Crit Care Shock. 2006;9:9-15.Google Scholar
  30. 30.
    Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-1083.PubMedCrossRefGoogle Scholar
  31. 31.
    The European Stroke Initiative Executive Committee and the EUSI Writing Committee. European Stroke Initiative recommendations for stoke management: update 2003. Cerebrovasc Dis. 2003;16:311-337.CrossRefGoogle Scholar
  32. 32.
    Qureshi AI, Harris-lane P, Kirmani JF, et al. Treatment of acute hypertention in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med. 2006;34:1975-1980.PubMedCrossRefGoogle Scholar
  33. 33.
    Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol. 2005;105:402-410.PubMedCrossRefGoogle Scholar
  34. 34.
    Gifford RW, August PA, Cunningham G. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.Google Scholar
  35. 35.
    Diagnosis and management of preeclampsia and eclampsia: ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2002;99:159-167.CrossRefGoogle Scholar
  36. 36.
    Mabie WC, Gonzalez AR, Sibai BM, et al. A comparative trial of labtalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987;70:328-333.PubMedGoogle Scholar
  37. 37.
    Elatrous S, Nouira S, Ouanes BL, et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Inten Care Med. 2002;28:1281-1286.CrossRefGoogle Scholar
  38. 38.
    Haas CE, LeBlanc JM, Haas CE, et al. Acute postoperative hypertension: a review of therapeutic options. Am J Health System Pharm. 2004;61:1661-1673.Google Scholar

Additional Reading

  1. Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med. 1990;323:1177-1183.PubMedCrossRefGoogle Scholar
  2. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report. JAMA. 2003;289(19):2560-2572.PubMedCrossRefGoogle Scholar
  3. Flanigan JS, Vitberg D. Hypertension emergency and severe hypertension: what to treat, who to treat, and how to treat. Med Clin N Am. 2006;90(3):439-451.PubMedCrossRefGoogle Scholar
  4. Marik PE, Varon J. Hypertensive crisis: challenges and management. Chest. 2007;131:1949-1962.PubMedCrossRefGoogle Scholar
  5. Vaidya CK, Ouellette JR. Hypertensive urgency and emergency. Hosp Physician. 2007;43:43-50.Google Scholar
  6. Aggarwal M, Khan IA. Hypertensive crises: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24:135-146.PubMedCrossRefGoogle Scholar
  7. Herbert CJ, Vidt DG. Hypertensive crises. Prim Care Clin Office Pract. 2008;35:475-487.CrossRefGoogle Scholar
  8. Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol. 1998;9:133-142.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Kathleen J. Brennan
    • 1
  • Jesse Goldman
    • 2
  • Gilbert E. D’Alonzo
    • 3
  1. 1.Division of Pulmonary and Critical Care MedicineTemple University School of MedicinePhiladelphiaUSA
  2. 2.Department of Medicine, Section of NephrologyTemple University School of MedicinePhiladelphiaUSA
  3. 3.Pulmonary and Critical Care MedicineTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations